Asia Pacific Cell Therapy Market Worth $2.9 Billion By 2028
Asia Pacific Cell Therapy Industry Overview The Asia Pacific cell therapy market size was valued at USD 959.8 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 14.9% from 2021 to 2028. The development of stem cell banking facilities and the resultant increase in stem cell production is expected to improve the volumetric capabilities of the market at a regional and country level. This, in turn, is anticipated to drive the market. Moreover, advancements in the therapy landscape with respect to their efficiency and manufacturing are some other major drivers of the market. Gather more insights about the market drivers, restrains and growth of the Asia Pacific Cell Therapy Market The outbreak of the SARS-CoV-2 pandemic has further driven the market as currently, there are no robust treatments for infection treatment, particularly in severe cases. A broad range of differences in the clinical symptoms of patients is primarily due to the genom...